Octagon Capital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for ArriVent BioPharma, Inc. Common Stock, $0.0001 par value (AVBP)

Filing Manager
Octagon Capital Advisors LP
Reporting Manager
Octagon Capital Advisors LP
Security
ArriVent BioPharma, Inc. Common Stock, $0.0001 par value
Symbol
AVBP
Shares outstanding
40,225,592 shares
Disclosed Ownership
1,971,054 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:46:07 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Octagon Capital Advisors LP 4.9% 1,971,054 0 1,971,054 /s/ Ting Jia Managing Member
Octagon Investments Master Fund LP 1.9% 776,667 0 776,667 /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Octagon Private Opportunities Fund LP 2% 799,911 0 799,911 /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Octagon Special Opportunities Fund LP - Series 4 1% 394,476 0 394,476 /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia 4.9% 1,971,054 0 1,971,054 /s/ Ting Jia Ting Jia